Skip to main content

Cytosorbents Corp

CTSO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001175151

In the last 90 days, Cytosorbents Corp insiders filed 4 open-market purchases and 0 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $6.04M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Cytosorbents Corp changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of CTSO: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders96102+6
Shares17.5M17.5M+46.0K (+0.3%)
Value$151.6M$132.4M−$19.2M (−12.7%)

New holders (17)

Institutions that held Cytosorbents Corp at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to CTSO in Q2 2021
InstitutionSharesValue% of portfolio
M&G Investment Management Ltd150,144$1.20M0.01%
Dimensional Fund Advisors LP61,487$464.0K0.00%
Millennium Management LLC52,247$394.0K0.00%
ExodusPoint Capital Management, LP48,071$363.0K0.01%
ACT Capital Management, LLC35,000$265.0K0.14%
Jane Street Group, LLC28,191$213.0K0.00%
Marshall Wace, LLP17,458$132.0K0.00%
HRT Financial LP15,560$117.0K0.00%
Simplex Trading, LLC13,951$105.0K0.00%
Russell Investments Group, Ltd.13,101$98.0K0.00%
Advisory Services Network, LLC7,380$56.0K0.00%
Smithfield Trust Co6,200$47.0K0.00%
Point72 Hong Kong Ltd1,871$14.0K0.00%
Eaton Vance Management925$7.00K0.00%
Quantbot Technologies LP600$4.00K0.00%
FMR LLC1$00.00%
Signaturefd, LLC56$00.00%

Sold out (11)

Institutions that held Cytosorbents Corp at the end of Q1 2021 and filed for Q2 2021 without it.